Industry leaders speak to the challenges and innovations in Oncology clinical trials

Oncology is leading the precision medicine revolution, as clinical researchers identify biomarkers to target patient subsets with more effective treatments. Yet there remains a scarcity of available patients for targeted therapy trials, and capturing, standardizing and analyzing app, sensor, imaging and genomic data from disparate systems is often unreliable.

Hear from special guest speakers Reinhard Von Roemeling, Board Certified Oncologist and former SVP of Global Oncology at Merck KGaA, Robert Ford, M.D. Founder and Principal at Clinical Trials Imaging Consulting, LLC., Michele Becci, VP of Industry Strategy at Medidata, and Jason Mezey, PhD Statistical Geneticist and Cornell University Professor, and discover how increasingly sophisticated technology with advanced analytics is helping clinical investigators and trial leaders overcome these challenges, and learn how a data-driven approach is a catalyst for:
    •  Optimal study design that minimizes patient burden & improves enrollment
    •  Improved site selection, enrollment, and retention with multivariate models
    •  Unified Study Conduct that streamlines trial operations and data capture
    •  Ensure real-world impact of new medicines and faster approvals

Featured Speakers

Reinhard von Roemeling, MD

Board Certified Oncologist
Former SVP of Global Oncology, Merck KGaA

Reinhard von Roemeling, MD, is an innovative leader of clinical research and global drug development. He received his medical degree from the JWv Goethe University Medical School in Frankfurt am Main – Germany. He completed his specialty training and obtained board certifications in internal medicine, hematology and oncology in Germany and in the USA, with clinical practice as faculty of leading academic institutions including Univ of MN School of Medicine in Minneapolis, Albany Medical College, NY, and Fox Chase Comprehensive Cancer Center, Philadelphia, PA. Author of peer-reviewed 98 scientific publications and 167 abstracts; invited speaker. 

Robert R. Ford, MD

Founder and Principal
Clinical Trials Imaging Consulting, LLC.

Robert R. Ford, M.D. received his B.S. degree from Rutgers University in 1979 and his M.D. degree from Robert Wood Johnson Medical School in 1983. He completed an internship in Internal Medicine at Robert Wood Johnson University Medical Center and University Medical Center at Princeton. From 1984 to 1988 he completed a residency in Diagnostic Radiology at Cornell University Medical Center-New York Hospital, Memorial Sloane Kettering Cancer Center, and the Hospital for Special Surgery.

Michele Becci

Vice President, Industry Strategy
Medidata Solutions
Michele M. Becci, Vice President, Industry Strategy at Medidata Solutions, has nearly 30 years of experience in the life sciences industry. Since joining Medidata in 2013, Michele is responsible for helping to shape the industry strategy of the Medidata portfolio. Prior to her joining Medidata, Michele held various senior management positions in sales and marketing as part of Oracle’s Health Sciences Global Business Unit. She holds a B.A. in Microbiology and an M.B.A. in International Business. 

Jason Mezey, PhD

Statistical Geneticist and Professor
Cornell University
Jason is a Professor at Cornell University and Weill Cornell here in NYC.  Jason and members of the Mezey Lab have consulted with Medidata for over 2 years infusing us with ideas and talent related to Genomics and Machine Learning.  Because of his many contributions at the cutting edge of disease diagnosis and prediction using genomics, he was recently promoted to Full Professor. Jason’s PhD is in statistical genetics from Yale.
Date:  Tuesday, March 20, 2018
Time:  12pm ET / 9am PT
Duration:  1 Hour

Register now for this webinar